A detailed history of Roble, Belko & Company, Inc transactions in Select Sector Spdr Fund Health stock. As of the latest transaction made, Roble, Belko & Company, Inc holds 6,810 shares of XLV stock, worth $939,780. This represents 0.17% of its overall portfolio holdings.

Number of Shares
6,810
Previous 6,953 2.06%
Holding current value
$939,780
Previous $1.01 Million 3.55%
% of portfolio
0.17%
Previous 0.17%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

SELL
$143.3 - $157.24 $20,491 - $22,485
-143 Reduced 2.06%
6,810 $1.05 Million
Q2 2024

Aug 07, 2024

SELL
$138.43 - $147.09 $8,997 - $9,560
-65 Reduced 0.93%
6,953 $1.01 Million
Q4 2023

Feb 01, 2024

SELL
$123.14 - $136.38 $11,082 - $12,274
-90 Reduced 1.27%
7,018 $957,000
Q2 2023

Aug 04, 2023

SELL
$126.74 - $135.66 $47,780 - $51,143
-377 Reduced 5.04%
7,108 $943,000
Q1 2023

May 10, 2023

SELL
$124.15 - $135.82 $15,891 - $17,384
-128 Reduced 1.68%
7,485 $969,000
Q4 2022

Feb 08, 2023

SELL
$121.85 - $140.1 $29,609 - $34,044
-243 Reduced 3.09%
7,613 $1.03 Million
Q3 2022

Nov 14, 2022

SELL
$121.11 - $134.29 $12,232 - $13,563
-101 Reduced 1.27%
7,856 $951,000
Q2 2022

Aug 10, 2022

SELL
$119.89 - $142.83 $119 - $142
-1 Reduced 0.01%
7,957 $1.02 Million
Q1 2022

May 06, 2022

SELL
$126.55 - $139.44 $118,577 - $130,655
-937 Reduced 10.53%
7,958 $1.09 Million
Q4 2021

Feb 07, 2022

SELL
$125.34 - $141.49 $9,525 - $10,753
-76 Reduced 0.85%
8,895 $1.25 Million
Q3 2021

Nov 03, 2021

SELL
$127.07 - $136.85 $47,524 - $51,181
-374 Reduced 4.0%
8,971 $1.14 Million
Q2 2021

Aug 02, 2021

BUY
$116.39 - $126.03 $116 - $126
1 Added 0.01%
9,345 $1.18 Million
Q1 2021

May 12, 2021

SELL
$110.8 - $118.5 $19,279 - $20,619
-174 Reduced 1.83%
9,344 $1.09 Million
Q3 2020

Nov 10, 2020

SELL
$100.71 - $109.44 $57,706 - $62,709
-573 Reduced 5.68%
9,518 $1 Million
Q2 2020

Aug 10, 2020

SELL
$85.21 - $103.92 $63,907 - $77,940
-750 Reduced 6.92%
10,091 $1.01 Million
Q1 2020

May 05, 2020

BUY
$74.62 - $104.73 $74 - $104
1 Added 0.01%
10,841 $960,000
Q4 2019

Jan 13, 2020

SELL
$87.95 - $103.11 $57,431 - $67,330
-653 Reduced 5.68%
10,840 $1.1 Million
Q3 2019

Nov 13, 2019

BUY
$89.33 - $92.0 $89 - $92
1 Added 0.01%
11,493 $1.04 Million
Q2 2019

Aug 13, 2019

BUY
N/A
484 Added 4.4%
11,492 $1.07 Million
Q1 2019

May 10, 2019

SELL
N/A
-1,822 Reduced 14.2%
11,008 $1.01 Million
Q4 2018

Feb 13, 2019

SELL
N/A
-443 Reduced 3.34%
12,830 $1.11 Million
Q3 2018

Nov 14, 2018

SELL
N/A
-1,415 Reduced 9.63%
13,273 $1.26 Million
Q1 2018

May 14, 2018

SELL
N/A
-108 Reduced 0.73%
14,688 $1.2 Million
Q4 2017

Jan 30, 2018

SELL
N/A
-218 Reduced 1.45%
14,796 $1.22 Million
Q3 2017

Nov 08, 2017

BUY
N/A
15,014
15,014 $1.23 Million

Others Institutions Holding XLV

About SELECT SECTOR SPDR FUND-HEALTH


  • Ticker XLV
  • Sector ETFs
  • Industry ETFs
More about XLV
Track This Portfolio

Track Roble, Belko & Company, Inc Portfolio

Follow Roble, Belko & Company, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Roble, Belko & Company, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Roble, Belko & Company, Inc with notifications on news.